B of A Securities Initiates Coverage On Perspective Therapeutics with Buy Rating, Announces Price Target of $24
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has initiated coverage on Perspective Therapeutics (AMEX:CATX) with a Buy rating and set a price target of $24.
July 25, 2024 | 11:44 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
B of A Securities has initiated coverage on Perspective Therapeutics with a Buy rating and a price target of $24, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $24 by a reputable analyst from B of A Securities is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100